Somebody was complaining that recruitment was too slow. Now the same people will complain that DXB have forked out hefty sums to open up additional sites recruiting additional patients. Just can't win lol.
Although a CR can never be totally ruled out, an R&D rebate, 50m options heavily in the money, potential milestone payments of $350m from Advanz and Taiba plus any upfront payment from either a China or USA deal significantly reduces the chance of this happening.
Somebody was complaining that recruitment was too slow. Now the...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.005(1.32%) |
Mkt cap ! $208.9M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 37.3¢ | $209.6K | 552.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 178424 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 152 | 4 |
View Market Depth
| Last trade - 11.30am 03/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |